|
Oct 8
|
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
|
|
Oct 7
|
CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques
|
|
Oct 4
|
CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial
|
|
Dec 7
|
CytoDyn Announces Webcast to Provide Company Update
|